UNSPSC 51282946: Temafloxacin hydrochloride

This classification denotes a quinolone antibiotic with the molecular formula C21H18F3N3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OC5IGJ7J6I, chemically known as 3-quinolinecarboxylic acid, 1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride, (+-)- but generally known as temafloxacin hydrochloride, which bears US NIH Compound Identifier 60020.

UNSPSC 51282946 Temafloxacin hydrochloride, a Commodity code, nominally covers a specific fluoroquinolone antibiotic active pharmaceutical ingredient, but recent state and local procurement activity under this code shows no direct solicitations for temafloxacin itself. Instead, the tagged opportunities reflect broader pharmaceutical and medical supply procurement — the Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for doxycycline hyclate and ciprofloxacin hydrochloride tablets totaling $2,999,999.11 over three years, and Seminole County, Florida issued an IFB in June 2026 for naloxone and drug deactivation systems with quarterly deliveries. Neither opportunity directly involves temafloxacin; the code appears to be a catch-all category or a legacy tag that does not align with the actual pharmaceutical and medical device purchases being made.

Geographic activity centers on Florida and Illinois based on the two recent opportunities identified. The issuing bodies are a state health department (Illinois) and a county government (Seminole County), suggesting fragmented procurement across state and local health agencies rather than concentrated purchasing. The Illinois contract flowed through a cooperative purchasing vehicle (MMCAP Infuse consortium), indicating state and local reliance on piggyback agreements to standardize pharmaceutical sourcing and pricing. Without additional opportunities specifically referencing temafloxacin or closely related products, the code shows limited relevance to current state and local procurement practice in antibiotic supply.